| 000 | 01206 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250512090920.0 | ||
| 264 | 0 | _c19721006 | |
| 008 | 197210s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(72)91893-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGibson, G J | |
| 245 | 0 | 0 |
_aHypertensive crises and phenylpropanolamine. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cSep 1972 |
||
| 300 |
_a492-3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAmino Alcohols _xadverse effects |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCheese _xadverse effects |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMonoamine Oxidase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aPhenethylamines _xadverse effects |
| 650 | 0 | 4 |
_aPhenylpropanolamine _xadverse effects |
| 650 | 0 | 4 |
_aSympathomimetics _xadverse effects |
| 700 | 1 | _aWarrell, D A | |
| 773 | 0 |
_tLancet (London, England) _gvol. 2 _gno. 7775 _gp. 492-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(72)91893-4 _zAvailable from publisher's website |
| 999 |
_c4121015 _d4121015 |
||